Immunocore Holdings plc (IMCR) Revenue Breakdown by Product - Discounting Cash Flows
  • Enter your search keyword...
IMCR
Immunocore Holdings plc
IMCR (NASDAQ)
  • Financials

  • Immunocore Holdings plc Revenue Breakdown

Annual Quarterly

* (except for per share items) of GBP
Period Ending: 2025
12-31 		2024
12-31 		2023
12-31 		2022
12-31 		2021
12-31 		2020
12-31
Total
1234
Sale of Therapies
1234
Sale of Therapies (%)
1234
Collaboration Revenue
1234
Collaboration Revenue (%)
1234
Europe
1234
Europe (%)
1234
UNITED STATES
1234
UNITED STATES (%)
1234
International
1234
International (%)
1234
Eli Lilly
1234
Eli Lilly (%)
1234
Genentech
1234
Genentech (%)
1234
UK
1234
UK (%)
1234
GlaxoSmithKline
1234
GlaxoSmithKline (%)
1234

AI Insights

What are AI Insights?

AI Insights help you understand your data more easily. With just a click, the assistant looks at the current page, generates a report with key metrics, and highlights any interesting trends, patterns, or outliers. You can also ask the assistant follow-up questions.

Create a Free Account
AI Insights Example
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program

Ready to Leave?

Select "Logout" below if you are ready to end your current session.